Magenta Therapeutics (MGTA) Income Statement (2018 - 2023)
Income Statement report data from Jun 30, 2018 to Jun 30, 2023 for Magenta Therapeutics (MGTA).
Reported currency: USD
| Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue and COGS | |||||||||||||||||||||
Total Revenue | 970K (+102.08%) | 480K (-59.32%) | 1.18M (+0.85%) | 1.17M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit | 970K (+102.08%) | 480K (-59.32%) | 1.18M (+0.85%) | 1.17M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Expenses | |||||||||||||||||||||
Research And Development | 10M (+75.21%) | 5.85M (-40.49%) | 9.83M (+36.15%) | 7.22M (-37.76%) | 12M (-29.91%) | 17M (+26.24%) | 13M (+21.39%) | 11M (-2.96%) | 11M (-5.12%) | 12M (-4.32%) | 12M (+3.99%) | 12M (-6.50%) | 13M (-9.67%) | 14M (-25.39%) | 19M (+13.26%) | 17M (+23.01%) | 13M (+27.42%) | 11M (-14.93%) | 12M (+8.49%) | 11M (+17.98%) | 9.68M |
Selling General And Administrative | 2.49M (+7.79%) | 2.31M (+13.24%) | 2.04M (-7.69%) | 2.21M (-65.90%) | 6.48M (-11.11%) | 7.29M (+3.70%) | 7.03M (-5.64%) | 7.45M (+14.97%) | 6.48M (-7.03%) | 6.97M (+2.35%) | 6.81M (+3.18%) | 6.60M (-10.81%) | 7.40M (+1.65%) | 7.28M (+22.97%) | 5.92M (-3.27%) | 6.12M (+3.55%) | 5.91M (+1.72%) | 5.81M (+4.87%) | 5.54M (+4.92%) | 5.28M (+21.66%) | 4.34M |
Operating Expenses | 13M (+56.25%) | 8.16M (-31.26%) | 12M (+25.87%) | 9.43M (-47.84%) | 18M (-24.13%) | 24M (+18.32%) | 20M (+10.36%) | 18M (+3.63%) | 18M (-5.83%) | 19M (-1.94%) | 19M (+3.75%) | 18M (-8.15%) | 20M (-5.79%) | 21M (-13.80%) | 25M (+8.83%) | 23M (+17.06%) | 19M (+18.29%) | 16M (-8.81%) | 18M (+7.37%) | 17M (+19.03%) | 14M |
Operating Income | |||||||||||||||||||||
Operating Income | -11.78M (+53.39%) | -7.68M (-28.16%) | -10.69M (+29.58%) | -8.25M (-54.37%) | -18.08M (-24.13%) | -23.83M (+18.32%) | -20.14M (+10.42%) | -18.24M (+3.58%) | -17.61M (-5.83%) | -18.70M (-1.94%) | -19.07M (+3.75%) | -18.38M (-8.15%) | -20.01M (-5.79%) | -21.24M (-13.80%) | -24.64M (+8.83%) | -22.64M (+17.06%) | -19.34M (+18.29%) | -16.35M (-8.81%) | -17.93M (+7.37%) | -16.70M (+19.12%) | -14.02M |
EBITDA | -11.76M (+53.32%) | -7.67M (-28.72%) | -10.76M (+17.72%) | -9.14M (-48.10%) | -17.61M (-24.49%) | -23.32M (+18.98%) | -19.60M (+10.67%) | -17.71M (+3.39%) | -17.13M (-5.98%) | -18.22M (-1.88%) | -18.57M (+3.80%) | -17.89M (-8.35%) | -19.52M (-5.93%) | -20.75M (-14.08%) | -24.15M (+8.98%) | -22.16M (+17.31%) | -18.89M (+18.58%) | -15.93M (-9.33%) | -17.57M (+6.55%) | -16.49M (+18.98%) | -13.86M |
Other Income / Expenses | |||||||||||||||||||||
Interest Income | 690K (+13.11%) | 610K (-4.69%) | 640K (+52.38%) | 420K (-48.15%) | 810K (-7.95%) | 880K (+3.53%) | 850K (+3.66%) | 820K (+20.59%) | 680K (-43.80%) | 1.21M (+34.44%) | 900K (+28.57%) | 700K (-24.73%) | 930K (-24.39%) | 1.23M (-12.14%) | 1.40M (-15.15%) | 1.65M (+1.23%) | 1.63M (+7.24%) | 1.52M (+21.60%) | 1.25M (+81.16%) | 690K (+86.49%) | 370K |
Net Interest Income | 690K (+13.11%) | 610K (-4.69%) | 640K (+52.38%) | 420K (-48.15%) | 810K (-7.95%) | 880K (+3.53%) | 850K (+3.66%) | 820K (+20.59%) | 680K (-43.80%) | 1.21M (+34.44%) | 900K (+28.57%) | 700K (-24.73%) | 930K (-24.39%) | 1.23M (-12.14%) | 1.40M (-15.15%) | 1.65M (+1.23%) | 1.63M (+7.24%) | 1.52M (+21.60%) | 1.25M (+81.16%) | 690K (+86.49%) | 370K |
Other Non Operating Income | -50.00K (+400.00%) | -10.00K (-83.33%) | -60.00K | 50K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Net Income | |||||||||||||||||||||
Income Before Tax | -11.14M (+57.12%) | -7.09M (-29.94%) | -10.12M (+30.08%) | -7.78M (-54.95%) | -17.27M (-24.75%) | -22.95M (+18.97%) | -19.29M (+10.67%) | -17.43M (+2.95%) | -16.93M (-3.20%) | -17.49M (-3.74%) | -18.17M (+2.77%) | -17.68M (-7.34%) | -19.08M (-4.65%) | -20.01M (-13.90%) | -23.24M (+10.72%) | -20.99M (+18.52%) | -17.71M (+19.42%) | -14.83M (-11.09%) | -16.68M (+4.18%) | -16.01M (+17.20%) | -13.66M |
Net Income From Continuing Operations | -11.14M (+57.12%) | -7.09M (-29.94%) | -10.12M (+30.08%) | -7.78M (-54.95%) | -17.27M (-24.75%) | -22.95M (+18.97%) | -19.29M (+10.67%) | -17.43M (+2.95%) | -16.93M (-3.20%) | -17.49M (-3.74%) | -18.17M (+2.77%) | -17.68M (-7.34%) | -19.08M (-4.65%) | -20.01M (-13.90%) | -23.24M (+10.72%) | -20.99M (+18.52%) | -17.71M (+19.42%) | -14.83M (-11.09%) | -16.68M (+4.18%) | -16.01M (+17.20%) | -13.66M |
Net Income | -11.14M (+57.12%) | -7.09M (-29.94%) | -10.12M (+30.08%) | -7.78M (-54.95%) | -17.27M (-24.75%) | -22.95M (+18.97%) | -19.29M (+10.67%) | -17.43M (+2.95%) | -16.93M (-3.20%) | -17.49M (-3.74%) | -18.17M (+2.77%) | -17.68M (-7.34%) | -19.08M (-4.65%) | -20.01M (-13.90%) | -23.24M (+10.72%) | -20.99M (+18.52%) | -17.71M (+19.42%) | -14.83M (-11.09%) | -16.68M (+4.18%) | -16.01M (+17.20%) | -13.66M |